Company Information
As of 5/23/2022
Country
U.S.
Headquarters
Wilmington, Del.
Industry
Pharmaceuticals
CEO
Hervé Hoppenot
Website
Company Type
Public
Ticker
INCY
Revenues ($M)
$2,986.3
Profits ($M)
$948.6
Market Value ($M)
$17,577.6
Employees
2,094
Market value as of March 31, 2022.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$2,986.3
12%
Profits ($M)
$948.6
-
Assets ($M)
$4,933.4
-
Total Stockholder Equity ($M)
$3,770
-
Profit Ratios
Profit as % of Revenues
31.8%
Profits as % of Assets
19.2%
Profits as % of Stockholder Equity
25.2%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
427
EPS % Change (from 2020)
-
EPS % Change (5 year annual rate)
51.2%
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
-15.6%
Total Return to Investors (5 year, annualized)
-6%
Total Return to Investors (10 year, annualized)
17.2%
Incyte Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $2,666.723.5% | $-295.7-166.2% | $3,560.9 | $2,611.3 |
| 2020 | $2,158.814.7% | $446.9308.2% | $3,426.8 | $2,598.4 |
Lists ranking Incyte
